These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 20170699

  • 1. Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia.
    Yasui-Furukori N, Saito M, Nakagami T, Sugawara N, Sato Y, Tsuchimine S, Furukori H, Kaneko S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):537-40. PubMed ID: 20170699
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of smoking status on the plasma concentration of prolactin already elevated by risperidone treatment in schizophrenia patients.
    Ohta C, Yasui-Furukori N, Furukori H, Tsuchimine S, Saito M, Nakagami T, Yoshizawa K, Kaneko S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):573-6. PubMed ID: 21216266
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
    David SR, Taylor CC, Kinon BJ, Breier A.
    Clin Ther; 2000 Sep 30; 22(9):1085-96. PubMed ID: 11048906
    [Abstract] [Full Text] [Related]

  • 9. [Prolactin secretion disturbances in schizophrenic patients treated with 2nd generation antipsychotics--risperidone and olanzapine].
    Wyszogrodzka-Kucharska A, Kunert-Radek J, Rabe-Jabłońska J.
    Psychiatr Pol; 2005 Sep 30; 39(6):1143-55. PubMed ID: 16526181
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine.
    Kinon BJ, Ahl J, Liu-Seifert H, Maguire GA.
    Psychoneuroendocrinology; 2006 Jun 30; 31(5):577-88. PubMed ID: 16488084
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescents.
    Migliardi G, Spina E, D'Arrigo C, Gagliano A, Germanò E, Siracusano R, Diaz FJ, de Leon J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov 13; 33(8):1496-501. PubMed ID: 19706318
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study.
    Wampers M, Hanssens L, van Winkel R, Heald A, Collette J, Peuskens J, Reginster JY, Scheen A, De Hert M.
    Eur Neuropsychopharmacol; 2012 Jan 13; 22(1):17-26. PubMed ID: 21511441
    [Abstract] [Full Text] [Related]

  • 16. Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.
    Volavka J, Czobor P, Cooper TB, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Lieberman JA.
    J Clin Psychiatry; 2004 Jan 13; 65(1):57-61. PubMed ID: 14744169
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.
    Kim KS, Pae CU, Chae JH, Bahk WM, Jun TY, Kim DJ, Dickson RA.
    J Clin Psychiatry; 2002 May 13; 63(5):408-13. PubMed ID: 12019665
    [Abstract] [Full Text] [Related]

  • 19. Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study.
    Smith RC, Lindenmayer JP, Davis JM, Kelly E, Viviano TF, Cornwell J, Hu Q, Khan A, Vaidhyanathaswamy S.
    J Clin Psychiatry; 2009 Nov 13; 70(11):1501-13. PubMed ID: 19814947
    [Abstract] [Full Text] [Related]

  • 20. Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials.
    Kinon BJ, Gilmore JA, Liu H, Halbreich UM.
    Psychoneuroendocrinology; 2003 Apr 13; 28 Suppl 2():69-82. PubMed ID: 12650682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.